Year: 2021

news_6

Jefferies to Hold “Doing Good” Global Trading Day on February 26 to Support Organizations Focused on Diversity & Inclusion, COVID-19 Relief and the Sustainability and Protection of Our Environment

news_6

Takeda’s Maribavir Phase 3 Clinical Trial Met Primary Endpoint of Superiority to Conventional Antiviral Therapy in Transplant Recipients With Refractory, With or Without Resistance, Cytomegalovirus Infection/Disease

More Than Twice As Many Transplant Recipients With Refractory, With or Without Resistance (R/R), Cytomegalovirus (CMV) Infection/Disease Treated With Maribavir,...